ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

This CHMP positive opinion paves the way to expand the use of dolutegravir in a younger population.